AOBiome

Last updated
AOBiome
Type of business Private
Founded2013
Headquarters,
United States
Key peopleLenny Barshack
James Heywood
Hilly Thompson
David Whitlock
URL www.aobiome.com
Current statusActive

AOBiome is a Boston-based biotech company focused on transforming human health through products that restore ammonia-oxidizing bacteria (AOB). The company is developing a novel class of therapeutics to improve skin health, hypertension, and other systemic conditions.

Contents

Company

The company was founded in 2013 by MIT chemical engineer David Whitlock and PatientsLikeMe founder Jamie Heywood, along with co-founders Hilly Thompson and Lenny Barshack.

History

In 2001 while on a date near some horse stables, engineer David Whitlock was asked why horses roll in the dirt. [1] Not knowing the answer, he studied soil samples and hypothesized that the Nitrosomonas eutropha that he found present was a key species as these bacteria feed on ammonia and thus could provide a symbiotic ammonia processing function for horses and other vertebrates. To test this theory he suspended the bacteria in water and coated himself with them and then stopped bathing in order to give the AOB a chance to colonize his body. Whitlock has reported in national media that he has not had a shower in over 10 years, but washes his hands before eating, [2] with a number of journalists confirming that he does not smell bad as a result. [3] Whitlock has speculated, along the lines of the "hygiene hypothesis", that modern lifestyle changes such as the adoption of frequent bathing and synthetic cosmetics have led to the death of so-called "old friend" bacteria which previously performed important functions in the body. [4]

AOBiome was founded in 2013 with a mission to study the effects of AOB on the skin microbiome and overall skin health. They have since performed in-vitro studies, in-vivo studies, and two human studies in acne vulgaris, the results of which have led the company to now additionally explore systemic therapies for conditions such as hypertension. [5] [6] [7] [8] The company has a patent covering the topical use of AOB. [9]

Ammonia-oxidizing bacteria

Ammonia-oxidizing bacteria (AOB) are a naturally occurring type of nitrifying bacteria that metabolize the ammonia found in sweat, creating nitrite and nitric oxide. [10] AOBiome is testing the hypothesis that by increasing local and systemic nitric oxide levels, this bacteria has both anti-inflammatory and anti-infective properties. [11] While the therapeutic potential of nitrite and nitric oxide is widely recognized, the bacteria are sensitive to the ingredients in most modern soaps and beauty products. AOBiome's cosmetic partner Mother Dirt is therefore the first skincare company to formulate products that support the growth of healthy bacteria.

Clinical trials

AOBiome is developing topical biologics for the treatment of inflammatory conditions, specifically looking at the therapeutic properties of ammonia-oxidizing bacteria. AOBiome started its Phase 2 clinical trial for adult acne in 2015. AOBiome has received attention for its prospective interventional study on the link between a bacteria-infused topical spray and hypertension. The Wall Street Journal describes that "Although the company knew when it began work on treating acne that nitric oxide has a beneficial effect on hypertension, it didn't expect to see such a strong reduction of blood pressure in the [acne] study." [12]

They are also looking into related therapies for allergic rhinitis and eczema (Phase I trials) as well as wound healing, migraines, and thermoregulation (preclinical trials).

Related Research Articles

<span class="mw-page-title-main">Acne</span> Skin condition characterized by pimples

Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to lack of confidence, anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

<span class="mw-page-title-main">Minocycline</span> Antibiotic medication

Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as some occurring in certain forms of pneumonia. It is generally less preferred than the tetracycline doxycycline. Minocycline is also used for the treatment of acne and rheumatoid arthritis. It is taken by mouth or applied to the skin.

<span class="mw-page-title-main">Nitrification</span> Biological oxidation of ammonia/ammonium to nitrate

Nitrification is the biological oxidation of ammonia to nitrate via the intermediary nitrite. Nitrification is an important step in the nitrogen cycle in soil. The process of complete nitrification may occur through separate organisms or entirely within one organism, as in comammox bacteria. The transformation of ammonia to nitrite is usually the rate limiting step of nitrification. Nitrification is an aerobic process performed by small groups of autotrophic bacteria and archaea.

The nitrite ion has the chemical formula NO
2
. Nitrite is widely used throughout chemical and pharmaceutical industries. The nitrite anion is a pervasive intermediate in the nitrogen cycle in nature. The name nitrite also refers to organic compounds having the –ONO group, which are esters of nitrous acid.

<span class="mw-page-title-main">Tretinoin</span> Medication

Tretinoin, also known as all-trans retinoic acid (ATRA), is a medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream, gel or ointment. For leukemia, it is taken by mouth for up to three months. Topical tretinoin is also the most extensively investigated retinoid therapy for photoaging.

<span class="mw-page-title-main">Adapalene</span> Third-generation topical retinoid

Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions. Studies have found adapalene is as effective as other retinoids, while causing less irritation. It also has several advantages over other retinoids. The adapalene molecule is more stable compared to tretinoin and tazarotene, which leads to less concern for photodegradation. It is also chemically more stable compared to the other two retinoids, allowing it to be used in combination with benzoyl peroxide. Due to its effects on keratinocyte proliferation and differentiation, adapalene is superior to tretinoin for the treatment of comedonal acne and is often used as a first-line agent. The Swiss company Galderma sells adapalene under the brand name Differin.

<span class="mw-page-title-main">Tetrahydrobiopterin</span> Chemical compound

Tetrahydrobiopterin (BH4, THB), also known as sapropterin (INN), is a cofactor of the three aromatic amino acid hydroxylase enzymes, used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), melatonin, dopamine, norepinephrine (noradrenaline), epinephrine (adrenaline), and is a cofactor for the production of nitric oxide (NO) by the nitric oxide synthases. Chemically, its structure is that of a (dihydropteridine reductase) reduced pteridine derivative (quinonoid dihydrobiopterin).

Nitrosomonas europaea is a Gram-negative obligate chemolithoautotroph that can derive all its energy and reductant for growth from the oxidation of ammonia to nitrite and lives in several places such as soil, sewage, freshwater, the walls of buildings and on the surface of monuments especially in polluted areas where the air contains high levels of nitrogen compounds.

<i>Nitrosomonas</i> Genus of bacteria

Nitrosomonas is a genus of Gram-negative bacteria, belonging to the Betaproteobacteria. It is one of the five genera of ammonia-oxidizing bacteria and, as an obligate chemolithoautotroph, uses ammonia as an energy source and carbon dioxide as a carbon source in presence of oxygen. Nitrosomonas are important in the global biogeochemical nitrogen cycle, since they increase the bioavailability of nitrogen to plants and in the denitrification, which is important for the release of nitrous oxide, a powerful greenhouse gas. This microbe is photophobic, and usually generate a biofilm matrix, or form clumps with other microbes, to avoid light. Nitrosomonas can be divided into six lineages: the first one includes the species Nitrosomonas europea, Nitrosomonas eutropha, Nitrosomonas halophila, and Nitrosomonas mobilis. The second lineage presents the species Nitrosomonas communis, N. sp. I and N. sp. II, meanwhile the third lineage includes only Nitrosomonas nitrosa. The fourth lineage includes the species Nitrosomonas ureae and Nitrosomonas oligotropha and the fifth and sixth lineages include the species Nitrosomonas marina, N. sp. III, Nitrosomonas estuarii and Nitrosomonas cryotolerans.

Denitrifying bacteria are a diverse group of bacteria that encompass many different phyla. This group of bacteria, together with denitrifying fungi and archaea, is capable of performing denitrification as part of the nitrogen cycle. Denitrification is performed by a variety of denitrifying bacteria that are widely distributed in soils and sediments and that use oxidized nitrogen compounds such as nitrate and nitrite in the absence of oxygen as a terminal electron acceptor. They metabolize nitrogenous compounds using various enzymes, including nitrate reductase (NAR), nitrite reductase (NIR), nitric oxide reductase (NOR) and nitrous oxide reductase (NOS), turning nitrogen oxides back to nitrogen gas or nitrous oxide.

<span class="mw-page-title-main">Clindamycin/benzoyl peroxide</span> Type of medication

Clindamycin/benzoyl peroxide, sold under the brand name Benzaclin among others, is a topical gel used for the treatment of acne. It is a fixed-dose combination of clindamycin, as the phosphate, an antibiotic; and benzoyl peroxide, an antiseptic.

A nitrate test is a chemical test used to determine the presence of nitrate ion in solution. Testing for the presence of nitrate via wet chemistry is generally difficult compared with testing for other anions, as almost all nitrates are soluble in water. In contrast, many common ions give insoluble salts, e.g. halides precipitate with silver, and sulfate precipitate with barium.

Nitrifying bacteria are chemolithotrophic organisms that include species of genera such as Nitrosomonas, Nitrosococcus, Nitrobacter, Nitrospina, Nitrospira and Nitrococcus. These bacteria get their energy from the oxidation of inorganic nitrogen compounds. Types include ammonia-oxidizing bacteria (AOB) and nitrite-oxidizing bacteria (NOB). Many species of nitrifying bacteria have complex internal membrane systems that are the location for key enzymes in nitrification: ammonia monooxygenase, hydroxylamine oxidoreductase, and nitrite oxidoreductase.

<i>Nitrosopumilus</i> Genus of archaea

Nitrosopumilus is a genus of archaea. The type species, Nitrosopumilus maritimus, is an extremely common archaeon living in seawater. It is the first member of the Group 1a Nitrososphaerota to be isolated in pure culture. Gene sequences suggest that the Group 1a Nitrososphaerota are ubiquitous with the oligotrophic surface ocean and can be found in most non-coastal marine waters around the planet. It is one of the smallest living organisms at 0.2 micrometers in diameter. Cells in the species N. maritimus are shaped like peanuts and can be found both as individuals and in loose aggregates. They oxidize ammonia to nitrite and members of N. maritimus can oxidize ammonia at levels as low as 10 nanomolar, near the limit to sustain its life. Archaea in the species N. maritimus live in oxygen-depleted habitats. Oxygen needed for ammonia oxidation might be produced by novel pathway which generates oxygen and dinitrogen. N. maritimus is thus among organisms which are able to produce oxygen in dark.

Naproxcinod (nitronaproxen) is a nonsteroidal anti-inflammatory drug (NSAID) developed by the French pharmaceutical company NicOx. It is a derivative of naproxen with a nitroxybutyl ester to allow it to also act as a nitric oxide (NO) donor. This second mechanism of action makes naproxcinod the first in a new class of drugs, the cyclooxygenase inhibiting nitric oxide donators (CINODs), that are hoped to produce similar analgesic efficacy to traditional NSAIDs, but with less gastrointestinal and cardiovascular side effects.

Biological functions of nitric oxide are roles that nitric oxide plays within biology.

<span class="mw-page-title-main">SHARON Wastewater Treatment</span>

SHARON is a sewage treatment process. A partial nitrification process of sewage treatment used for the removal of ammonia and organic nitrogen components from wastewater flow streams. The process results in stable nitrite formation, rather than complete oxidation to nitrate. Nitrate formation by nitrite oxidising bacteria (NOB) is prevented by adjusting temperature, pH, and retention time to select for nitrifying ammonia oxidising bacteria (AOB). Denitrification of waste streams utilizing SHARON reactors can proceed with an anoxic reduction, such as anammox.

Ammonia monooxygenase (EC 1.14.99.39, AMO) is an enzyme, which catalyses the following chemical reaction

<span class="mw-page-title-main">Clascoterone</span> Chemical compound

Clascoterone, sold under the brand name Winlevi, is an antiandrogen medication which is used topically in the treatment of acne. It is also under development in a higher concentration for the treatment of androgen-dependent scalp hair loss, under the brand name Breezula. The medication is used as a cream by application to the skin, for instance the face and scalp.

Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent.

References

  1. Scott, Julia (May 22, 2014). "My No-Soap, No-Shampoo, Bacteria-Rich Hygiene Experiment". The New York Times. ISSN   0362-4331. Archived from the original on June 9, 2017. Retrieved June 14, 2017.
  2. "No Shower, No Problem — Just Spritz With Bacteria". NPR.org. Archived from the original on April 23, 2017. Retrieved June 14, 2017.
  3. "David Whitlock Hasn't Showered In 13 Years!". WGBH News. 2016-03-22. Retrieved June 14, 2017.
  4. Whitlock, David R.; Feelisch, Martin (2009). Rook, Graham A. W. (ed.). The Hygiene Hypothesis and Darwinian Medicine. Progress in Inflammation Research. Birkhäuser Basel. pp. 103–115. doi:10.1007/978-3-7643-8903-1_6. ISBN   9783764389024.
  5. Gormley, Brian (2016-12-15). "AOBiome Stumbles Upon Blood-Pressure Target After Starting on Acne". Wall Street Journal. ISSN   0099-9660. Archived from the original on 2018-05-26. Retrieved 2017-06-14.
  6. "A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 2020-11-03. Retrieved 2017-06-14.
  7. "Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Archived from the original on 2017-11-06. Retrieved 2017-06-14.
  8. "A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. 3 April 2017. Archived from the original on 2021-03-27. Retrieved 2017-06-14.
  9. "Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same". Google Patents. 2001-08-10. Retrieved 2024-06-26.
  10. Jones, Mitchell Lawrence; Ganopolsky, Jorge Gabriel; Labbé, Alain; Wahl, Christopher; Prakash, Satya (2010-09-01). "Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices". Applied Microbiology and Biotechnology. 88 (2): 401–407. doi:10.1007/s00253-010-2733-x. ISSN   0175-7598. PMID   20680266. S2CID   7018678.
  11. "'I don't smell!' Meet the people who have stopped washing". TheGuardian.com . 5 August 2019.
  12. Gormley, Brian (December 15, 2016). "AOBiome Stumbles Upon Blood-Pressure Target After Starting on Acne". Wall Street Journal. ISSN   0099-9660. Archived from the original on May 26, 2018. Retrieved June 14, 2017.